Antineoplastics and immunomodulators 2026-II Cytostatikums content of the active substance nintedanib
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Antineoplastics and immunomodulators 2026-II Cytostatikums content of the active substance nintedanib
P.o. forma s content of 100 mg nitroglycerin v unit form for therapy ILD, predpokládaný roční objem 14 700 unit form (dávek); p.o
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals